<DOC>
	<DOC>NCT02582801</DOC>
	<brief_summary>18F-Alfatide Ⅱ PET/CT in breast cancer patients</brief_summary>
	<brief_title>Clinical Research of 18F-Alfatide Ⅱ PET/CT in Breast Cancer</brief_title>
	<detailed_description>The investigators aim to assess the clinical application of 18F-Alfatide Ⅱ PET/CT in the diagnosis and treatment response monitoring of breast cancer.</detailed_description>
	<mesh_term>Breast Neoplasms</mesh_term>
	<criteria>The patients have been suspected or diagnosed with breast cancer and they have not received any treatment; It must fulfill the ethical requirements and subjects have signed an informed consent. Pregnancy or nursing mothers; Those patients accompanied by other serious diseases such as cardiac functional insufficiency, hepatic and renal function insufficiency.</criteria>
	<gender>Female</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>70 Years</maximum_age>
	<verification_date>August 2016</verification_date>
	<keyword>PET/CT</keyword>
	<keyword>Alfatide Ⅱ</keyword>
	<keyword>breast cancer</keyword>
</DOC>